Can a video call diagnose Alzheimer's as well as a Doctor's office visit?
NCT ID NCT05379023
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether doing memory and thinking tests over a video call at home works as well as doing them in person for people with suspected Alzheimer's disease. 116 older adults (ages 60-90) with mild memory problems took part. The goal was to see if video assessments are a practical and accurate way to help doctors tell the difference between typical and atypical Alzheimer's.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
116 people
The number who actually took part.
- Started
-
Jun 2022
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Individuals age 60 to 90 years who are undergoing evaluation for possible AD and whose severity ranges from MCI to mild dementia. * Individuals must carry a diagnosis of either suspected typical AD or atypical AD, based on the referring neurologist's diagnosis. Exclusion Criteria: * Individuals with moderate to severe levels of dementia and individuals with active delirium (per neurologist's determination). * Individuals who are legally blind or deaf, due to the auditory and visual components of the study. * Individuals with a brain tumor and individuals who have a confirmed nonAD neurological diagnosis (e.g, Multiple Sclerosis; FTD). * Individuals who are being evaluated outside of the UCH Memory Disorders Clinic. * Individuals who report active (i.e., within the last 6 months) substance use of illicit drugs such as cocaine or methamphetamines, or who carry a diagnosis of a major psychiatric disorder (e.g., schizophrenia; bipolar disorder). Note that care partners (3rd arm) did not undergo the intervention and there were no additional eligibility requirements for them except that they were involved in the patient's care
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Suspected atypical Alzheimer's disease (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Colorado Anschutz Medical Campus (CU-AMC)
Aurora, Colorado, 80045, United States